← Browse by Condition
Medical Condition

who grade glioma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06482905 Phase 1
Recruiting

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Enrollment
52 pts
Location
United States, China
Sponsor
Tcelltech Inc.
View Trial →